Wei, Yongkun

PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression

Jiao, S., Xia, W., Yamaguchi, H., Wei, Y., Chen, M.-K., Hsu, J.-M., Hsu, J. L., Yu, W.-H., Du, Y., Lee, H.-H., et al. (2017) · Clinical Cancer Research

PARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers

Cited by 981

The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

Xu, D., Wang, Z., Xia, Y., Shao, F., Xia, W., Wei, Y., Li, X., Qian, X., Lee, J.-H., Du, L., et al. (2020) · Nature

Cancer, Lipids, and MetabolismLipid metabolism and biosynthesis

Cited by 360

MDM2 Promotes Cell Motility and Invasiveness by Regulating E-Cadherin Degradation

Yang, J.-Y., Zong, C. S., Xia, W., Wei, Y., Ali-Seyed, M., Li, Z., Broglio, K., Berry, D. A., & Hung, M.-C. (2006) · Molecular and Cellular Biology

Ubiquitin and proteasome pathwaysCancer-related Molecular Pathways

Cited by 211

Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKβ overexpression in human breast cancers

Ping, B., He, X., Xia, W., Lee, D.-F., Wei, Y., Yu, D., Mills, G., Shi, D., & Hung, M.-C. (2006) · International Journal of Oncology

NF-κB Signaling PathwaysCancer-related Molecular Pathways

Cited by 7

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Theardy, M. S., Takeda, M., Sorokin, A., Chen, S., Yang, Z., Wang, X., Kanikarla, P., Coker, O., Nguyen, P., Wei, Y., et al. (2025) · Cell Reports Medicine

Protein Kinase Regulation and GTPase SignalingHippo pathway signaling and YAP/TAZ

Cited by 6